LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced that effective March 1, 2011, Brian McCollum has been promoted to Chief Financial Officer. Mr. McCollum had been serving as the Company’s Interim Chief Financial Officer since January 2011. Mr. McCollum has been with the Company for close to 10 years in various roles of increasing responsibilities. Mr. McCollum will be responsible for overseeing all financial activities including investor relations. Alan Milinazzo, the Company’s President and Chief Executive Officer, stated, “We are delighted to be able to promote Brian into the CFO position. Throughout his 10 year tenure with Orthofix he has taken on roles of increasing responsibility, including successfully serving as the Vice President of Finance for our largest domestic and international business units which gives him tremendous insight into our businesses worldwide.”
Orthofix International, N.V. is a global medical device company offering a broad line of minimally invasive surgical and non-surgical products for the spine, orthopedic, and sports medicine market sectors, that address the lifelong bone-and-joint health needs of patients of all ages - helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating and investing in R&D activities with leading medical institutions such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, The University of Medicine and Dentistry of New Jersey and the National Osteoporosis Institute. For more information about Orthofix, please visit www.orthofix.com.
Orthofix International N.V.
Brian McCollum, 214-937-2927
Chief Financial Officer
KEYWORDS: United States North America Texas
INDUSTRY KEYWORDS: Stem Cells Surgery Health Biotechnology Hospitals Medical Devices